Engaging the Cancer
Fight
The Two Important
Platforms of Cancer Research
It becomes necessary to engage defense on two main platforms.
The first is detection of cells with the “bad” DNA message and second
recruiting all of the active defense cells and the necessary immune mechanisms
that initiate eradication of the cell with the “bad” (cancer cell) message. DNA
is the genetic matrix material of every living cell. DNA is known as the “double
helix” and replicates in a uniform regulated fashion. When DNA is damaged it
becomes overexpressed and the checkpoints in replication are altered causing
the continuous replication of single-strand DNA. This damage to DNA is caused
by mutations, which impairs the cells normal signaling balance. DNA then
continues to replicate in the nucleus of the harmed cell and impairs every
function of the cell. Additionally, the harmed cell’s life and replication
cycles are overexpressed and each offspring produced from the original harmed
cell can express the same mutation as well as additional mutations making it
virtually impossible to respond to one type of treatment approach. Therefore,
it becomes essential to re-think the development of cancer treatment making it
necessary to address different cancer types with their set mutations
specifically.
As noted above DNA damage detection and discovery of repair
mechanisms are of primary importance. When DNA replication and regulatory
communication checkpoints are distorted or impaired there are numerous specific
proteins altered. Research and discovery of these regulatory proteins of DNA is
vital importance. The figures below demonstrate DNA damage and its consequences
on cell health and development.